EVENT DATE: April 12-14, 2019
Cardiovascular disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite the tremendous advances in cardiac care made recently, including drugs, devices, and diagnostic innovations, many patients continue to die from heart disease or live with significant morbidity. Challenges for the next decade include health promotion and disease prevention, obesity and diabetes, and acute heart failure and cardiorenal disease. We must broaden our scope of intervention to emphasize and extend preventive strategies, and translate our innovations into affirmative actions through carefully designed health policy strategies. Artificial intelligence, along with genomic and proteomic biomarkers, promise to improve early detection and risk stratification, leading to a more personalized approach to cardiovascular medicine.
This year, our meeting is held jointly with the 7th International Ottawa Heart Conference.
We have developed a joint program that will bring delegates together to learn about the exciting advances in cardiovascular disease and cardiometabolic medicine. The combined conference program has been designed to appeal to a wide audience and will feature guideline updates, interactive workshops, poster presentations, as well as opportunities for networking and mutual learning. The three-day program will allow key opinion leaders and trainees to share the latest research findings and clinical treatments regarding cardiovascular disease with health care practitioner and scientists across Canada, as well as share the latest developments in big data science as it relates to patients with cardiovascular disease.
To enhance the learning experience, the symposium features lectures, panel discussions, problem-solving sessions, and case presentations to foster interaction between the faculty and delegates. The case-based presentations will be particularly valuable in translating theoretical concepts and guidelines, to practice.